by Yannis Natsis | Nov 30, 2021 | #EU4Health, Universal Access and Affordable Medicines | Analysis & Opinion
The EU’s Pharmaceutical Strategy is a roadmap which will accompany policy developments for the years to come. It is important as it offers a rare and concise overview of actions and priorities which guide EU policy action. It is indeed a reference point as much as a...
by Milka Sokolović | Jul 8, 2021 | #EU4Health, The View from EPHA, Universal Access and Affordable Medicines | Analysis & Opinion
The access to medicines debate in Europe is at a critical juncture. With the pandemic, all issues, old and new, suddenly find a place on the agenda. They range from the prices of medicines, the flexibility of regulatory standards, the quality of innovation, all the...
by Yannis Natsis | Jul 8, 2021 | Universal Access and Affordable Medicines | Analysis & Opinion
Undeniably, pharmaceutical companies’ power and influence have grown in the context of the current pandemic. The politicisation of pharmaceuticals is unprecedented. Pharma CEOs pick up the phone and talk directly to EU heads of state and governments. Companies are...
by European Public Health Alliance | Jul 8, 2021 | Universal Access and Affordable Medicines | Analysis & Opinion
Guest article: Ella Weggen & Marianne Meijer, Global Health Advovates, WemosTRIPS waiver, C-TAP, the use of compulsory licensing, donations through COVAX – various strategies have been proposed to increase global access to COVID-19 vaccines. One way or another,...
by European Public Health Alliance | Jul 8, 2021 | Universal Access and Affordable Medicines | Analysis & Opinion
By Jaume Vidal, Senior Policy Advisor, Health Action InternationalThe COVID-19 pandemic, and the efforts of governments and international organisations to counter it, has laid bare the pre-existing contradictions and shortcomings in the current biomedical research and...
by European Public Health Alliance | Mar 30, 2021 | Cancer, Universal Access and Affordable Medicines | Analysis & Opinion
Guest article: Lydie Meheus, Belgian AntiCancer FundTo fight cancer, Europe needs a whole-of-government approach that puts patients’ needs at the centre, driving change for the benefit of citizens and reducing the suffering caused by cancer. The Anticancer Fund...
